Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Boner

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Israel Journal of Medical Sciences|December 1, 1996
Progression of renal disease--can it be reversed? The role of calcium channel blockers and angiotensin-converting enzyme inhibitorsG Boner
EDTNA/ERCA Journal (English Ed.)|February 18, 2005
Management of diabetic nephropathy: epidemiology, pathogenesis of nephropathy and factors influencing progressionG Boner
Lancet (London, England)|November 27, 1982
Uric acid and diabetesG Boner
Harefuah|January 16, 1983
[Neoplastic disease in patients receiving dialytic therapy and in patients after receiving transplantation]G Boner, H Kristal
Nephron|January 1, 1997
Adequacy of hemodialysis 1996J Shohat, G Boner
Harefuah|September 1, 1979
[The compensatory changes in the size and functions of a single kidney after unilateral nephrectomy]G Boner, E Mukamel
Harefuah|May 15, 1985
[Sclerodermal renal crisis]Y Traub, G Boner
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2004
Dual blockade of the renin-angiotensin system in diabetic nephropathyM Cooper, G Boner
Harefuah|November 15, 1974
[Editorial: HL-A histocompatibility and a national transplant registry]E Jacob, G Boner
Israel Journal of Medical Sciences|April 1, 1993
Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesisJ Shohat, G Boner
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Israel Journal of Medical Sciences|December 1, 1996
Progression of renal disease--can it be reversed? The role of calcium channel blockers and angiotensin-converting enzyme inhibitorsG Boner
EDTNA/ERCA Journal (English Ed.)|February 18, 2005
Management of diabetic nephropathy: epidemiology, pathogenesis of nephropathy and factors influencing progressionG Boner
Lancet (London, England)|November 27, 1982
Uric acid and diabetesG Boner
Harefuah|January 16, 1983
[Neoplastic disease in patients receiving dialytic therapy and in patients after receiving transplantation]G Boner, H Kristal
Nephron|January 1, 1997
Adequacy of hemodialysis 1996J Shohat, G Boner
Harefuah|September 1, 1979
[The compensatory changes in the size and functions of a single kidney after unilateral nephrectomy]G Boner, E Mukamel
Harefuah|May 15, 1985
[Sclerodermal renal crisis]Y Traub, G Boner
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2004
Dual blockade of the renin-angiotensin system in diabetic nephropathyM Cooper, G Boner
Harefuah|November 15, 1974
[Editorial: HL-A histocompatibility and a national transplant registry]E Jacob, G Boner
Israel Journal of Medical Sciences|April 1, 1993
Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesisJ Shohat, G Boner
Pageof 16